Clinical Trial Detail

NCT ID NCT03343613
Title A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

Advanced Solid Tumor

head and neck squamous cell carcinoma

transitional cell carcinoma

lung non-small cell carcinoma

Therapies

LY3300054 + LY3381916

LY3381916

Age Groups: adult senior

No variant requirements are available.